CRHEA is a CNRS laboratory located in Sophia Antipolis, is a leader laboratory in France and Europe in the epitaxy of GaN, SiC and ZnO based materials by MBE and VPE. Applications span from power electronics to optoelectronics. CRHEA’s staff is about 65 people including 15 PhD students. CRHEA also has all the necessary characterization equipment such as SEM and TEM, AFM, X ray diffraction for structural characterizations, but also a large panel of optical and electrical measurement techniques. Moreover, various kind of devices can be processed in the CRHEATEC cleanroom that is a regional facility for micro-nano technologies. In scope with the NECTAR project objectives, the CRHEA has a large experience in GaN based detector elaboration and characterization acquired over the years for UV, extreme UV, and X rays devices.
IMPT-CAL (Institut Méditerranéen de ProtonThérapie – Centre Antoine Lacassagne) is a clinic with long-term experience in proton therapy, hosting two proton therapy facilities: the MEDICYC line (65 MeV) commissioned in June 1991, and the Proteus One (235MeV) installed in 2016. Beyond the clinical expertise, the medical physics group is involved for more than 10 years in Monte Carlo simulation of particle transport for dosimetric, quality assurance, radiation safety, and imaging purposes. After patient treatments generally occurring in the morning, the experimental area of the MEDICYC proton accelerator is available for testing particle detectors. Therefore, the IMPT-CAL is not only a state-of-the-art therapy treatment platform but it also integrates a real medical research policy.